Skip to main content
Clinical Trials/IRCT20211206053291N1
IRCT20211206053291N1Recruiting未知

The effect of intravenous lidocaine on reducing the complications of endotracheal intubation after cardiac surgery

Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran0 sites90 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor
Enrollment
90

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 85 years (—)
Sex
All

Inclusion Criteria

  • simple cardiac surgury(CABG or valvular)
  • No history of smoking and drug or alcohol addiction during the last 10 years before surgery
  • No history of any drug or food allergies
  • All patients took beta-blockers around the operation and in the morning
  • No history of lung problems (asthma, COPD, etc.) treated with oral or inhaled drugs

Exclusion Criteria

  • Dangerous arrhythmia during or after surgery
  • Hemodynamic instability including: cardiac instability (patients treated with epinephrine or levofed at doses above 1.1 µg / kg) and respiratory instability (po2=60mmhg or pco2=50) during postoperative time
  • Bleeding so much that the patient becomes a candidate for reoperation
  • Injection of lidocaine for any reason after surgery
  • EF drop after surgery
  • Use of ECMO or pump balloons after surgery

Investigators

Sponsor
Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran

Similar Trials